GB1492746A - Androstane derivatives and compositions containing them - Google Patents
Androstane derivatives and compositions containing themInfo
- Publication number
- GB1492746A GB1492746A GB2211/74A GB221174A GB1492746A GB 1492746 A GB1492746 A GB 1492746A GB 2211/74 A GB2211/74 A GB 2211/74A GB 221174 A GB221174 A GB 221174A GB 1492746 A GB1492746 A GB 1492746A
- Authority
- GB
- United Kingdom
- Prior art keywords
- isomer
- androst
- jan
- pure
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Abstract
1492746 #<SP>2</SP>-Androstenes THERAMEX SA 17 Jan 1975 [17 Jan 1974] 02211/74 Heading C2U [Also in Division A5] The invention comprises 17α-ethynyl-5α- androst-2-en-17#-ol and its acetate free from their respective #<SP>3</SP>-isomers; and their preparation from the analogously pure corresponding 17-one by reaction with an alkali metal salt (simple or complex) of acetylene, followed when required by acetylation. 5α - Androst - 2 - en - 17 - one is freed from admixed #<SP>3</SP>-isomer thereof by treatment with Jones reagent and isolation of the pure #<SP>2</SP> compound from the resultant mixture, e.g. by crystallization or chromatography. (The #<SP>3</SP>- isomer is thought to be converted to a diacid or aldehyde while the #<SP>2</SP>-isomer remains unchanged). The inventive compounds are credited with pituitary gonadotrophin-stimulating, gonadinhibiting, antitumour, contraceptive, anti-parathyroid and anti-seborrhoeic activities, and may be made up with carriers into pharmaceutical compositions for oral, parenteral, topical and rectal administration.
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2211/74A GB1492746A (en) | 1974-01-17 | 1974-01-17 | Androstane derivatives and compositions containing them |
CH1734774A CH606091A5 (en) | 1974-01-17 | 1974-12-18 | |
BE151716A BE823594A (en) | 1974-01-17 | 1974-12-19 | PROCESS FOR OBTAINING THE COMPOUND 17 ALPHA-ETHINYL (5 ALPHA) 2-ANDROSTENE 17 BETA-OL IN THE PURE STATE AND THERAPEUTIC APPLICATIONS OF THE COMPOUND OBTAINED |
DK690574AA DK135538B (en) | 1974-01-17 | 1974-12-30 | Process for the preparation of 17alpha-ethynyl- (5alpha) -2-androsten-17-beta-ol. |
FR7443397A FR2258185B1 (en) | 1974-01-17 | 1974-12-31 | |
ES433677A ES433677A1 (en) | 1974-01-17 | 1975-01-09 | Androstane derivatives and compositions containing them |
DE19752501091 DE2501091A1 (en) | 1974-01-17 | 1975-01-13 | 17-ALPHA-AETHINYL- (5-ALPHA) -2-ANDROSTEN-17-BETA-OL AND ITS 17-BETA-ACETATE, METHOD FOR THEIR MANUFACTURING AND THERAPEUTIC USE |
ZA00750254A ZA75254B (en) | 1974-01-17 | 1975-01-14 | 17 alpha-ethynyl (5-alpha), 2-androsten, 17 beta-ol |
JP698075A JPS576439B2 (en) | 1974-01-17 | 1975-01-14 | |
AU77335/75A AU521392B2 (en) | 1974-01-17 | 1975-01-15 | 17-alpha-ethynyl-(5-alpha)-2-androsten-17-beta-ol and its beta-acetate |
CA218,033A CA1065851A (en) | 1974-01-17 | 1975-01-16 | Process for the preparation of pure 17-alpha-ethinyl (5 alpha) 2-androstene 17 beta-ol and therapeutical application thereof |
IT19319/75A IT1044268B (en) | 1974-01-17 | 1975-01-16 | PROCEDURE FOR THE PREPARATION OF THE COMPOUND 17 ALFA ETINIL 5 ALFA 2 ANDROSTENE 17 BETA OL AND ITS ACETATE 17 BETA IN THE PURE STATE ITS MIXTURE TO ITS DELTA 3 ISOMER AND THE THERAPEUTIC APPLICATIONS OF THE COMPOUND OBTAINED WITH THE PROCEDURE |
PH16719A PH15366A (en) | 1974-01-17 | 1975-01-16 | 17-alpha ethynyl,(5-alpha)-2-androsten,17-beta-ol and its beta agetate not mixed with its delta-3-isomers and the therapeutic applications of the compound |
LU71662A LU71662A1 (en) | 1974-01-17 | 1975-01-16 | |
SE7500479A SE7500479L (en) | 1974-01-17 | 1975-01-16 | |
IE83/75A IE40477B1 (en) | 1974-01-17 | 1975-01-17 | Androstane derivatives and compositions containing them |
BR346/75A BR7500346A (en) | 1974-01-17 | 1975-01-17 | PROCESS FOR OBTAINING COMPOUND 17-ALPHA-ETHINYL (5-ALPHA) -2-ANDROSTENE 17-BETA-OL AND ITS 17-BETA-ACETATE IN PURE STATE THE COMPOUND PRODUCED ITS MIXTURE WITH ITS DELTA-3 ISOMER AND THE APPLICATIONS OF COMPOUND OBTAINED BY THE PROCESS |
NLAANVRAGE7500608,A NL183402C (en) | 1974-01-17 | 1975-01-17 | PROCESS FOR PREPARING 17-ALFA-ETHYNYL- (5-ALFA) -2-ANDROSTONE-17-BETA-OL, ITS ACETATE, METHOD FOR PREPARING A MEDICINAL PRODUCT, AND PREPARED PREPARED THEREOF. |
AR257331A AR203672A1 (en) | 1974-01-17 | 1975-01-17 | PROCEDURE FOR OBTAINING IN THE COMPOSITE STATE 17ALPHA-ETHINYL (5ALPHA) -2-ANDROSTENE, 17BETA-OL, AND ITS 17BETA-ACETATE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2211/74A GB1492746A (en) | 1974-01-17 | 1974-01-17 | Androstane derivatives and compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1492746A true GB1492746A (en) | 1977-11-23 |
Family
ID=9735557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2211/74A Expired GB1492746A (en) | 1974-01-17 | 1974-01-17 | Androstane derivatives and compositions containing them |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS576439B2 (en) |
AR (1) | AR203672A1 (en) |
AU (1) | AU521392B2 (en) |
BE (1) | BE823594A (en) |
BR (1) | BR7500346A (en) |
CA (1) | CA1065851A (en) |
CH (1) | CH606091A5 (en) |
DE (1) | DE2501091A1 (en) |
DK (1) | DK135538B (en) |
ES (1) | ES433677A1 (en) |
FR (1) | FR2258185B1 (en) |
GB (1) | GB1492746A (en) |
IE (1) | IE40477B1 (en) |
IT (1) | IT1044268B (en) |
LU (1) | LU71662A1 (en) |
NL (1) | NL183402C (en) |
PH (1) | PH15366A (en) |
SE (1) | SE7500479L (en) |
ZA (1) | ZA75254B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0066001A1 (en) * | 1981-06-02 | 1982-12-08 | Laboratoire Théramex | Pharmaceutical compositions containing androstenes |
WO1986001208A1 (en) * | 1984-08-17 | 1986-02-27 | Sri International | Stereoisometrically pure 17-alpha-ethynyl-estra-2-en-17beta-ol and esters thereof |
FR2598083A1 (en) * | 1986-05-05 | 1987-11-06 | Theramex Laboratoire | NOVEL PHARMACEUTICAL COMPOSITIONS WITH ANTIPROGESTERONIC ACTION AND PROCESS FOR OBTAINING THEM |
US5116830A (en) * | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60173248A (en) * | 1984-02-16 | 1985-09-06 | 三晃金属工業株式会社 | Inlaid outer enclosure |
EP0200591B1 (en) * | 1985-04-29 | 1989-01-18 | Laboratoire Theramex | Process for the preparation of pure androst-2-ene derivatives |
RU2652702C2 (en) | 2016-10-19 | 2018-04-28 | Игорь Ву-Юнович Ван | Sub-atmospheric system of heat and cold supply |
-
1974
- 1974-01-17 GB GB2211/74A patent/GB1492746A/en not_active Expired
- 1974-12-18 CH CH1734774A patent/CH606091A5/xx not_active IP Right Cessation
- 1974-12-19 BE BE151716A patent/BE823594A/en unknown
- 1974-12-30 DK DK690574AA patent/DK135538B/en not_active IP Right Cessation
- 1974-12-31 FR FR7443397A patent/FR2258185B1/fr not_active Expired
-
1975
- 1975-01-09 ES ES433677A patent/ES433677A1/en not_active Expired
- 1975-01-13 DE DE19752501091 patent/DE2501091A1/en active Pending
- 1975-01-14 JP JP698075A patent/JPS576439B2/ja not_active Expired
- 1975-01-14 ZA ZA00750254A patent/ZA75254B/en unknown
- 1975-01-15 AU AU77335/75A patent/AU521392B2/en not_active Expired
- 1975-01-16 SE SE7500479A patent/SE7500479L/xx unknown
- 1975-01-16 IT IT19319/75A patent/IT1044268B/en active
- 1975-01-16 LU LU71662A patent/LU71662A1/xx unknown
- 1975-01-16 CA CA218,033A patent/CA1065851A/en not_active Expired
- 1975-01-16 PH PH16719A patent/PH15366A/en unknown
- 1975-01-17 AR AR257331A patent/AR203672A1/en active
- 1975-01-17 BR BR346/75A patent/BR7500346A/en unknown
- 1975-01-17 NL NLAANVRAGE7500608,A patent/NL183402C/en not_active IP Right Cessation
- 1975-01-17 IE IE83/75A patent/IE40477B1/en unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0066001A1 (en) * | 1981-06-02 | 1982-12-08 | Laboratoire Théramex | Pharmaceutical compositions containing androstenes |
WO1986001208A1 (en) * | 1984-08-17 | 1986-02-27 | Sri International | Stereoisometrically pure 17-alpha-ethynyl-estra-2-en-17beta-ol and esters thereof |
US5116830A (en) * | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
FR2598083A1 (en) * | 1986-05-05 | 1987-11-06 | Theramex Laboratoire | NOVEL PHARMACEUTICAL COMPOSITIONS WITH ANTIPROGESTERONIC ACTION AND PROCESS FOR OBTAINING THEM |
Also Published As
Publication number | Publication date |
---|---|
CA1065851A (en) | 1979-11-06 |
AU521392B2 (en) | 1982-04-01 |
PH15366A (en) | 1982-12-10 |
FR2258185A1 (en) | 1975-08-18 |
IT1044268B (en) | 1980-03-20 |
SE7500479L (en) | 1975-07-18 |
JPS576439B2 (en) | 1982-02-04 |
AR203672A1 (en) | 1975-09-30 |
CH606091A5 (en) | 1978-10-13 |
DE2501091A1 (en) | 1975-07-24 |
DK135538C (en) | 1977-10-24 |
FR2258185B1 (en) | 1978-07-28 |
NL7500608A (en) | 1975-07-21 |
AU7733575A (en) | 1976-07-15 |
DK690574A (en) | 1975-09-29 |
IE40477B1 (en) | 1979-06-06 |
ZA75254B (en) | 1976-01-28 |
NL183402C (en) | 1988-10-17 |
ES433677A1 (en) | 1976-11-16 |
JPS50106952A (en) | 1975-08-22 |
IE40477L (en) | 1975-07-17 |
LU71662A1 (en) | 1975-06-24 |
DK135538B (en) | 1977-05-16 |
NL183402B (en) | 1988-05-16 |
BR7500346A (en) | 1975-11-04 |
BE823594A (en) | 1975-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1429922A (en) | Steroid acetals processes for their manufacture and preparations containing them | |
MY104375A (en) | Vitamin d derivatives and process for their preparation. | |
GB1515284A (en) | Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series | |
GB1492746A (en) | Androstane derivatives and compositions containing them | |
GB1373548A (en) | Anti-hypertensive 6-substituted 3-hydrazino-pyridazines and their preparation | |
GB1453906A (en) | 3-deoxyglucose derivatives | |
YU44372A (en) | Process for obtaining pregnane acid derivatives | |
GB1424297A (en) | Process for vapour phase ammoxidation | |
US2888471A (en) | Process for preparing 17alpha-ethinyl-delta1, 4-androstadiene-17 beta-ol-3-one | |
GB1461051A (en) | Bufatrienolide rhamnoside ethers and a process for their preparation | |
GB1397434A (en) | Evomonoside derivatives | |
ES446623A1 (en) | Steroid carboxylic acids and derivatives | |
GB1348941A (en) | 6,6-difluoro-pregnenes-3,17-diones | |
GB1363150A (en) | 17alpha-propadienyl steroids | |
GB887337A (en) | New benzo-bis-imidazoles and process for their manufacture | |
GB1386439A (en) | Substituted gonenes processes for their preparation and compositions incorporating them | |
GB1336703A (en) | 17alpha-ethynylestriols and process for preparaing same | |
GB1503805A (en) | Halo-steroidal thioketals | |
GB1501592A (en) | Pharmaceutical compositions | |
GB1050249A (en) | ||
GB1265446A (en) | ||
GB1324612A (en) | Epoxy estranes processes for their preparation and compositions incorporating them | |
GB1504294A (en) | 6 beta-fluoropregnane compounds | |
GB1388443A (en) | Selective reduction of 9,15-dioxoprostanoic acids | |
GB1510431A (en) | Tri-cyclic compounds derived from phloroglucinal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |